0001209191-18-042389.txt : 20180711
0001209191-18-042389.hdr.sgml : 20180711
20180711180524
ACCESSION NUMBER: 0001209191-18-042389
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180709
FILED AS OF DATE: 20180711
DATE AS OF CHANGE: 20180711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cumbo Alexander
CENTRAL INDEX KEY: 0001685994
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 18949357
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-09
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001685994
Cumbo Alexander
215 FIRST STREET
SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
SVP, Chief Commercial Officer
Common Stock
2018-07-09
4
M
0
11924
13.71
A
40690
D
Common Stock
2018-07-09
4
S
0
11924
137.32
D
28766
D
Common Stock
2018-07-09
4
M
0
9944
13.71
A
38710
D
Common Stock
2018-07-09
4
S
0
9944
137.32
D
28766
D
Common Stock
2018-07-09
4
M
0
11914
13.90
A
40680
D
Common Stock
2018-07-09
4
S
0
11914
137.32
D
28766
D
Stock option (right to buy)
13.71
2018-07-09
4
M
0
11924
13.71
D
2017-02-28
2026-02-28
Common Stock
11924
3850
D
Stock option (right to buy)
13.71
2018-07-09
4
M
0
9944
13.71
D
2017-02-28
2026-02-28
Common Stock
9944
3895
D
Stock option (right to buy)
13.90
2018-07-09
4
M
0
11914
13.90
D
2016-02-27
2025-02-27
Common Stock
11914
2250
D
This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 8, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.
/s/ David Tyronne Howton, as Attorney-in-Fact for Alexander Cumbo
2018-07-11